Your browser doesn't support javascript.
loading
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
Worden, Francis P; Taylor, Jeremy M G; Biermann, Janet S; Sondak, Vernon K; Leu, Kirstin M; Chugh, Rashmi; McGinn, Cornelius J; Zalupski, Mark M; Baker, Laurence H.
Afiliação
  • Worden FP; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
J Clin Oncol ; 23(1): 105-12, 2005 Jan 01.
Article em En | MEDLINE | ID: mdl-15625365
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antineoplásicos Alquilantes / Ifosfamida / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antineoplásicos Alquilantes / Ifosfamida / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article